Rocco D. Gogliotti

1.5k citations

31 papers · 1.1k indexed · h-index 19

Virology top 2%
- HIV Research and Treatment 6
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 7
Cellular and Molecular Neuroscience top 10%
- Neuroscience and Neuropharmacology Research 9
Molecular Biology
- Receptor Mechanisms and Signaling 7
- Ion channel regulation and function 5
- Cancer therapeutics and mechanisms 4
- Protein Degradation and Inhibitors 3
Organic Chemistry top 10%
- Synthesis and Characterization of Heterocyclic Compounds 2

Co-authors: Joseph P. Sanchez John M. Domagala Craig W. Lindsley Tod P. Holler Shaun R. Stauffer Patricia J. Harvey Joseph A. Loo Donald Hupe
Cited by: Virology Infectious Diseases Cellular and Molecular Neuroscience
Journals: Journal of Medicinal Chemistry (9 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Bioorganic & Medicinal Chemistry (2 papers)
Partner nations: United States Australia Ukraine

In The Last Decade

Rocco D. Gogliotti

31 papers receiving 1.0k citations

Peers

Countries citing papers authored by Rocco D. Gogliotti

Since Specialization

Citations

This map shows the geographic impact of Rocco D. Gogliotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocco D. Gogliotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocco D. Gogliotti more than expected).

Fields of papers citing papers by Rocco D. Gogliotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocco D. Gogliotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocco D. Gogliotti. The network helps show where Rocco D. Gogliotti may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rocco D. Gogliotti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rocco D. Gogliotti Line = papers co-authored together Rocco D. Gogliotti links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A fragment‐based approach to discovery of Receptor for Advanced Glycation End products inhibitors Proteins Structure Function and Bioinformatics ·Jazi Abdullah,Benjamin A. Gilston,Pambayun Ellys Lestari,Rocco D. Gogliotti,Plamen P. Christov,Kwangho Kim,Kai Xu,Alex G. Waterson,Walter Chazin	2021	10
2	Discovery of Potent 2-Aryl-6,7-dihydro-5 H -pyrrolo[1,2- a ]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design Journal of Medicinal Chemistry ·Feng Wang,Kyu Ok Jeon,James M. Salovich,Jonathan D. Macdonald,Joseph Alvarado,Rocco D. Gogliotti,Jason Phan,Edward T. Olejniczak,Qi Sun,Shidong Wang,DeMarco V. Camper,D. Schönfeld,J. Grace Shaw,Jiqing Sai,Olivia W. Rossanese,William P. Tansey,Shaun R. Stauffer,Stephen W. Fesik	2018	50
3	Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy Bioorganic & Medicinal Chemistry Letters ·Rocco D. Gogliotti,Darren W. Engers,Pedro M. García-Barrantes,Joseph D. Panarese,Patrick R. Gentry,Anna L. Blobaum,Ryan D. Morrison,J. Scott Daniels,Analisa D. Thompson,Carrie K. Jones,P. Jeffrey Conn,Colleen M. Niswender,Craig W. Lindsley,Corey R. Hopkins	2016	3
4	Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4) Bioorganic & Medicinal Chemistry Letters ·Rocco D. Gogliotti,Anna L. Blobaum,Eun Kim Sung,J. Scott Daniels,James M. Salovich,Phoebe J. Becktell,Alice L. Rodriguez,Hilary Livia Dove,P. Jeffrey Conn,Craig W. Lindsley,Colleen M. Niswender,Corey R. Hopkins	2016	5
5	Discovery, Synthesis, and Preclinical Characterization ofN-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu₄) ACS Chemical Neuroscience ·Darren W. Engers,Anna L. Blobaum,Rocco D. Gogliotti,Phoebe J. Becktell,James M. Salovich,Pedro M. García-Barrantes,J. Scott Daniels,Ryan D. Morrison,Carrie K. Jones,Matthew G. Soars,Xiaoliang Zhuo,S. Yaknesh,John E. Macor,Joanne J. Bronson,P. Jeffrey Conn,Craig W. Lindsley,Colleen M. Niswender,Corey R. Hopkins	2016	39
6	Progress towards small molecule menin-mixed lineage leukemia (MLL) interaction inhibitors with in vivo utility Bioorganic & Medicinal Chemistry Letters ·Hyun-Sang Choi,Rocco D. Gogliotti,Changho Han,Charles W. Locuson,Ryan D. Morrison,J. Scott Daniels,Tomasz Cierpicki,Jolanta Grembecka,Craig W. Lindsley,Shaun R. Stauffer	2015	11
7	Eliciting Renal Failure in Mosquitoes with a Small-Molecule Inhibitor of Inward-Rectifying Potassium Channels PLoS ONE ·Rene Raphemot,Matthew F. Rouhier,Corey R. Hopkins,Rocco D. Gogliotti,Kimberly M. Lovell,好子水野,Siska Silviana Rizki,González Cevallos,Klaus W. Beyenbach,Jerod S. Denton,Peter M. Piermarini	2013	56
8	Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism Drug Metabolism and Disposition ·Thomas M. Bridges,Jerri M. Rook,Meredith J. Noetzel,Ryan D. Morrison,Ya Zhou,Rocco D. Gogliotti,Paige N. Vinson,Zixiu Xiang,Carrie K. Jones,Colleen M. Niswender,Craig W. Lindsley,Shaun R. Stauffer,P. Jeffrey Conn,J. Scott Daniels	2013	36
9	Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor Bioorganic & Medicinal Chemistry Letters ·Bruce J. Melancon,Rocco D. Gogliotti,James C. Tarr,Arayombo Arayemi Serah,Brian A. Chauder,Evan P. Lebois,Hyekyung P. Cho,Thomas J. Utley,Douglas J. Sheffler,Thomas M. Bridges,Ryan D. Morrison,J. Scott Daniels,Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley,Michael R. Wood	2012	14
10	Unique Signaling Profiles of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Determine Differences in In Vivo Activity Biological Psychiatry ·Jerri M. Rook,Meredith J. Noetzel,Wendy A. Pouliot,Thomas M. Bridges,Paige N. Vinson,Hyekyung P. Cho,Ya Zhou,Rocco D. Gogliotti,Jason Manka,Karen J. Gregory,Shaun R. Stauffer,F. Edward Dudek,Zixiu Xiang,Colleen M. Niswender,J. Scott Daniels,Carrie K. Jones,Craig W. Lindsley,P. Jeffrey Conn	2012	73
11	Discovery, Characterization, and Structure?Activity Relationships of an Inhibitor of Inward Rectifier Potassium (Kir) Channels with Preference for Kir2.3, Kir3.X, and Kir7.1 Frontiers in Pharmacology ·Rene Raphemot,Evelise Boliani,Thuy Thi Thanh Nguyen,Thomas J. Utley,L. Michelle Lewis,Rishin J. Kadakia,C. David Weaver,Rocco D. Gogliotti,Corey R. Hopkins,Craig W. Lindsley,Jerod S. Denton	2011	38
12	Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu₄) with Oral Efficacy in an Antiparkinsonian Animal Model Journal of Medicinal Chemistry ·Carrie K. Jones,Darren W. Engers,Analisa D. Thompson,Julie R. Field,Anna L. Blobaum,Stacey R. Lindsley,Ya Zhou,Rocco D. Gogliotti,Satyawan Jadhav,Rocio Zamorano,James W. Bogenpohl,Yoland Smith,Ryan D. Morrison,J. Scott Daniels,C. David Weaver,P. Jeffrey Conn,Craig W. Lindsley,Colleen M. Niswender,Corey R. Hopkins	2011	50
13	Role of Inhibitor Aliphatic Chain in the Thermodynamics of Inhibitor Binding to Escherichia coli Enoyl-ACP Reductase and the Phe203Leu Mutant: A Proposed Mechanism for Drug Resistance Biochemistry ·Irina I. Protasevich,Christie G. Brouillette,Mark E. Snow,Steve Dunham,John R. Rubin,Rocco D. Gogliotti,Karen Lohmann Siegel	2004	10
14	Inhibition of the early phase of HIV replication by an isothiazolone, PD 161374 Antiviral Research ·L Sharmeen,Thomas J. McQuade,Andrea Heldsinger,Rocco D. Gogliotti,John M. Domagala,Stephen J. Gracheck	2001	23
15	2,2′-dithiobisbenzamides derived from α-, β- and γ-amino acids possessing anti-HIV activities: synthesis and structure–activity relationship Bioorganic & Medicinal Chemistry ·J. V. N. Vara Prasad,Joseph A. Loo,F Boyer,Michael A. Stier,Rocco D. Gogliotti,William J. Turner,Patricia J. Harvey,David A. Cain,David P. Mack,Shital Telrandhe,Stephen J. Gracheck,John M. Domagala	1998	21
16	A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: The 2,2′-dithiobisbenzamides Bioorganic & Medicinal Chemistry ·John M. Domagala,John P. Bader,Rocco D. Gogliotti,Joseph P. Sanchez,Michael A. Stier,Yuntao Song,J. V. N. Vara Prasad,Peter J. Tummino,Jeffrey D. Scholten,Patricia J. Harvey,Tod P. Holler,Thiago Boldrini,Donald Hupe,William G. Rice,Robert Schultz	1997	33
17	The Synthesis, Structure-Activity, and Structure-Side Effect Relationships of a Series of 8-Alkoxy- and 5-Amino-8-alkoxyquinolone Antibacterial Agents Journal of Medicinal Chemistry ·Joseph P. Sanchez,Rocco D. Gogliotti,John M. Domagala,Stephen J. Gracheck,Michael D. Huband,Felice Rova,Michael A. Cohen,Martin A. Shapiro	1995	55
18	Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS Science ·William G. Rice,Jeffrey G. Supko,Louis Malspeis,Robert W. Buckheit,David J. Clanton,Ming Bu,Lisa M. Graham,Catherine A. Schaeffer,Jim A. Turpin,John M. Domagala,Rocco D. Gogliotti,John P. Bader,純志浅野,Lori V. Coren,Raymond C. Sowder,Larry O. Arthur,Louis E. Henderson	1995	195
19	New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk Journal of Medicinal Chemistry ·Joseph P. Sanchez,Alexander J. Bridges,D Baguelin,J. M. DOMAGALA,Rocco D. Gogliotti,Susan E. Hagen,Carl L. Heifetz,Motoki Asano,Naglaa Ahmed El-Adawy	1992	20
20	Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine Journal of Medicinal Chemistry ·John S. Kiely,Marland P. Hutt,Townley P. Culbertson,D Baguelin,Donald F. Worth,G. Vandana,Rocco D. Gogliotti,Naglaa Ahmed El-Adawy,Marjorie S. Solomon,T. F. MICH	1991	14

About Rocco D. Gogliotti

Rocco D. Gogliotti is a scholar working on Virology, Cellular and Molecular Neuroscience and Infectious Diseases, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (7 papers), HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers), Ion channel regulation and function (5 papers), Cancer therapeutics and mechanisms (4 papers), Protein Degradation and Inhibitors (3 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). The work is most often cited by research in Virology (251 citations), Infectious Diseases (277 citations) and Cellular and Molecular Neuroscience (229 citations). Rocco D. Gogliotti has collaborated with scholars based in United States, Australia and Ukraine. Frequent co-authors include Joseph P. Sanchez, John M. Domagala, Craig W. Lindsley, Tod P. Holler, Shaun R. Stauffer, Patricia J. Harvey, Joseph A. Loo, Donald Hupe, J. M. DOMAGALA and Peter J. Tummino. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry, ACS Chemical Neuroscience and Biological Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact